Skip to content

Insulin resistance increases risk of brain impairment for adults with HIV

US researchers estimate HIV treatment will work for 24 years and cost £200k

New risk factors for severe liver toxicity identified in largest ever clinical trial-based analysis

Kaletra not associated with raised blood pressure, manufacturer review reports

High risk of AIDS or death in HIV-positive individuals in South Africa ineligible for antiretrovirals

BHIVA: Late diagnosis responsible for at least a quarter of HIV deaths, testing implications discussed

BHIVA: One-in-three UK HIV deaths 'not directly related to HIV'

HIV-experienced physicians may reduce hospital stays and cost of inpatient care

Options for treating ganciclovir-resistant CMV discussed at IDSA conference